Elicera Therapeutics
5.54 SEK
-0.89 %
Less than 1K followers
ELIC
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Elicera Therapeutics
P/B
Median 2021-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | - | - | 5.02 | 3.52 | 4.56 | 1.67 | 5.22 |
| Shares | 19.8 | 19.8 | 19.8 | 19.8 | 19.8 | 35.1 | 48.5 |
| Market cap | - | - | 99.3 | 69.5 | 90.2 | 58.6 | 253.4 |
| Enterprise value | - | - | 46.9 | - | - | - | - |
| EV/S | - | - | 79.9 | - | - | - | - |
| EV/EBITDA | - | - | neg. | - | - | - | - |
| EV/EBIT | - | - | neg. | - | - | - | - |
| P/E | - | - | neg. | neg. | neg. | neg. | neg. |
| P/B | - | - | 1.90 | 2.12 | 5.50 | 2.82 | 10.85 |
| P/S | - | - | 169.2 | - | - | - | - |
| Dividend yield | - | - | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | - | 81.3 % | 95.4 % | 70.8 % | 54.3 % | 75.4 % | 85.2 % |
| Gearing ratio | - | - | - | - | - | - | - |